[go: up one dir, main page]

WO2009115084A3 - Pyrrolopyrimidin-derivate und deren verwendungen - Google Patents

Pyrrolopyrimidin-derivate und deren verwendungen Download PDF

Info

Publication number
WO2009115084A3
WO2009115084A3 PCT/DE2009/000369 DE2009000369W WO2009115084A3 WO 2009115084 A3 WO2009115084 A3 WO 2009115084A3 DE 2009000369 W DE2009000369 W DE 2009000369W WO 2009115084 A3 WO2009115084 A3 WO 2009115084A3
Authority
WO
WIPO (PCT)
Prior art keywords
pyrrolopyrimidine derivatives
derivatives
pyrrolopyrimidine
production
pharmaceutical compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/DE2009/000369
Other languages
English (en)
French (fr)
Other versions
WO2009115084A2 (de
Inventor
Hans Scheefers
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ScheBo Biotech AG
Original Assignee
ScheBo Biotech AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE200810021699 external-priority patent/DE102008021699A1/de
Application filed by ScheBo Biotech AG filed Critical ScheBo Biotech AG
Publication of WO2009115084A2 publication Critical patent/WO2009115084A2/de
Publication of WO2009115084A3 publication Critical patent/WO2009115084A3/de
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Die Erfindung betrifft neue Pyrrolopyrimidinderivate, die zur Herstellung von pharmazeutischen Zusammensetzungen geeignet sind.
PCT/DE2009/000369 2008-03-20 2009-03-20 Neue pyrrolopyrimidin-derivate und deren verwendungen Ceased WO2009115084A2 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE102008016183.7 2008-03-20
DE102008016183 2008-03-20
DE200810021699 DE102008021699A1 (de) 2008-04-25 2008-04-25 Neue Pyrrolopyrimidin-Derivate und deren Verwendung
DE102008021699.2 2008-04-25

Publications (2)

Publication Number Publication Date
WO2009115084A2 WO2009115084A2 (de) 2009-09-24
WO2009115084A3 true WO2009115084A3 (de) 2010-04-08

Family

ID=41091269

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DE2009/000369 Ceased WO2009115084A2 (de) 2008-03-20 2009-03-20 Neue pyrrolopyrimidin-derivate und deren verwendungen

Country Status (1)

Country Link
WO (1) WO2009115084A2 (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9096593B2 (en) 2009-11-06 2015-08-04 Plexxikon Inc. Compounds and methods for kinase modulation, and indications therefor

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008063888A2 (en) 2006-11-22 2008-05-29 Plexxikon, Inc. Compounds modulating c-fms and/or c-kit activity and uses therefor
CN102361870B (zh) 2009-04-03 2015-11-25 豪夫迈罗氏公司 丙烷-1-磺酸{3-[5-(4-氯-苯基)-1H-吡咯并[2,3-b]吡啶-3-羰基]-2,4-二氟-苯基}-酰胺组合物及其用途
CN102574860A (zh) 2009-10-15 2012-07-11 辉瑞大药厂 吡咯并[2,3-d]嘧啶化合物
UY33227A (es) 2010-02-19 2011-09-30 Novartis Ag Compuestos de pirrolopirimidina como inhibidores de la cdk4/6
TWI619713B (zh) 2010-04-21 2018-04-01 普雷辛肯公司 用於激酶調節的化合物和方法及其適應症
KR20140049961A (ko) 2010-11-29 2014-04-28 갈레온 파마슈티칼스, 인코포레이티드 호흡 조절 장애 또는 질병의 치료를 위한 호흡 자극제로서의 신규 화합물
US20120295911A1 (en) 2010-11-29 2012-11-22 Galleon Pharmaceuticals, Inc. Novel Compounds and Compositions for Treatment of Breathing Control Disorders or Diseases
JP5941069B2 (ja) 2011-02-07 2016-06-29 プレキシコン インコーポレーテッドＰｌｅｘｘｉｋｏｎ Ｉｎｃ． キナーゼ調節のための化合物および方法、ならびにそれに対する適応症
US9150570B2 (en) 2012-05-31 2015-10-06 Plexxikon Inc. Synthesis of heterocyclic compounds
EP3439664A1 (de) * 2016-04-08 2019-02-13 Novartis AG Neue therapeutische verwendungen

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999065908A1 (en) * 1998-06-19 1999-12-23 Pfizer Products Inc. PYRROLO[2,3-d]PYRIMIDINE COMPOUNDS
US20030139430A1 (en) * 2002-01-24 2003-07-24 Resta Debra Jane Use of organic compounds
WO2004093812A2 (en) * 2003-04-22 2004-11-04 Irm Llc Compounds that induce neuronal differentiation in embryonic stem cells
WO2005075460A2 (en) * 2004-01-29 2005-08-18 Novartis Ag Pyrrolopyrimidine derivatives for treating proliferative diseases

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999065908A1 (en) * 1998-06-19 1999-12-23 Pfizer Products Inc. PYRROLO[2,3-d]PYRIMIDINE COMPOUNDS
US20030139430A1 (en) * 2002-01-24 2003-07-24 Resta Debra Jane Use of organic compounds
WO2004093812A2 (en) * 2003-04-22 2004-11-04 Irm Llc Compounds that induce neuronal differentiation in embryonic stem cells
WO2005075460A2 (en) * 2004-01-29 2005-08-18 Novartis Ag Pyrrolopyrimidine derivatives for treating proliferative diseases

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9096593B2 (en) 2009-11-06 2015-08-04 Plexxikon Inc. Compounds and methods for kinase modulation, and indications therefor

Also Published As

Publication number Publication date
WO2009115084A2 (de) 2009-09-24

Similar Documents

Publication Publication Date Title
WO2009115084A3 (de) Pyrrolopyrimidin-derivate und deren verwendungen
WO2009135646A3 (en) Stable pharmaceutical compositions and their processes for preparation suitable for industrial scale
WO2012042371A3 (en) Pharmaceutical composition
WO2010115552A8 (en) Bispecific anti-erbb-3/anti-c-met antibodies
TW200800968A (en) Sulfoximine-substituted pyrimidines, processes for production thereof and use thereof as drugs
WO2010069532A8 (en) Antibodies against human angiopoietin 2
WO2010077740A3 (en) Novel antiviral compounds, compositions, and methods of use
WO2011077043A3 (fr) Derives phenoliques, et leur utilisation pharmaceutique ou cosmetique
WO2008132229A3 (en) Highly concentrated insulin solutions and compositions
WO2010092090A3 (en) Novel salts of sitagliptin
MX2011014019A (es) Derivados de diazahomoadamantano y sus metodos de uso.
WO2011098582A3 (en) Novel crystalline forms of ivabradine hydrochloride
WO2010049454A3 (en) Antimicrobial composition from copepods
WO2010055082A3 (en) New crystal form of sunitinib malate
WO2010048358A3 (en) Ethoxyphenylmethyl inhibitors of sglt2
WO2011009938A3 (en) Stambomycin and derivatives, their production and their use as drugs
WO2011017502A3 (en) Linaclotide-containing formulations for oral administration
IN2012DN02793A (de)
WO2012049307A3 (en) Novel n-terminally modified insulin derivatives
WO2010102778A3 (de) Substituierte 3-aminoisoxazolopyridine als kcnq2/3 modulatoren
WO2010049449A3 (en) Novel salts of sunitinib
WO2008129501A3 (en) Pharmaceutical compositions of duloxetine
WO2009094457A3 (en) Substituted benzhydrylethers
WO2010065586A3 (en) Preparation of capecitabine
WO2009035959A3 (en) Radiofluorination methods

Legal Events

Date Code Title Description
122 Ep: pct application non-entry in european phase

Ref document number: 09722938

Country of ref document: EP

Kind code of ref document: A2